Latest Adalimumab Stories
Tokyo, Sept 11, 2012 - (JCN Newswire) - Eisai Co., Ltd.
People suffering from ulcerative colitis may be getting some new relief due to a decision by the Food and Drug Administration (FDA) to open a new drug to help alleviate symptoms.
New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade).
- A small wooded valley; a dell.
- The protecting weather-shed built around the entrance to a house.
- The roofed-over space between the kitchen and the sleeping-quarters in a logging-camp, commonly used as a storeroom.